Mammalian Circadian Period, But Not Phase and Amplitude, Is Robust Against Redox and Metabolic Perturbations by Putker, M et al.
FORUM ORIGINAL RESEARCH COMMUNICATION
Mammalian Circadian Period, But Not Phase
and Amplitude, Is Robust Against Redox
and Metabolic Perturbations
Marrit Putker,1,*,{ Priya Crosby,1,{ Kevin A. Feeney,1 Nathaniel P. Hoyle,1
Ana S.H. Costa,2 Edoardo Gaude,2 Christian Frezza,2 and John S. O’Neill1
Abstract
Aims: Circadian rhythms permeate all levels of biology to temporally regulate cell and whole-body physiology,
although the cell-autonomous mechanism that confers *24-h periodicity is incompletely understood. Reports
describing circadian oscillations of over-oxidized peroxiredoxin abundance have suggested that redox signaling
plays an important role in the timekeeping mechanism. Here, we tested the functional contribution that redox
state and primary metabolism make to mammalian cellular timekeeping.
Results: We found a circadian rhythm in flux through primary glucose metabolic pathways, indicating rhythmic
NAD(P)H production. Using pharmacological and genetic perturbations, however, we found that timekeeping was
insensitive to changes in glycolytic flux, whereas oxidative pentose phosphate pathway (PPP) inhibition and other
chronic redox stressors primarily affected circadian gene expression amplitude, not periodicity. Finally, acute changes
in redox state decreased PER2 protein stability, phase dependently, to alter the subsequent phase of oscillation.
Innovation: Circadian rhythms in primary cellular metabolism and redox state have been proposed to play a
role in the cellular timekeeping mechanism. We present experimental data testing that hypothesis.
Conclusion: Circadian flux through primary metabolism is cell autonomous, driving rhythmic NAD(P)+ redox
cofactor turnover and maintaining a redox balance that is permissive for circadian gene expression cycles. Redox
homeostasis and PPP flux, but not glycolysis, are necessary to maintain clock amplitude, but neither redox nor
glucose metabolism determines circadian period. Furthermore, cellular rhythms are sensitive to acute changes in
redox balance, at least partly through regulation of PER protein. Redox and metabolic state are, thus, both inputs
and outputs, but not state variables, of cellular circadian timekeeping. Antioxid. Redox Signal. 00, 000–000.
Keywords: circadian rhythm, redox signaling, primary metabolism, clock gene, mammalian, pentose phosphate
pathway
Introduction
Mammalian cells exhibit cell-autonomous *24-hrhythms in the organization of a broad range of bio-
logical processes, from metabolism (11) to redox balance
(56), and from cell division (14) to DNA repair (67). At the
whole-organism level, these individual cellular rhythms are
synchronized by endocrine cues to facilitate anticipation of,
and adaptation to, the environmental cycle of day and night
(45). This is most evident in the daily cycle of human sleep
and wake, but it extends to regulate most aspects of physi-
ology and organismal function. In consequence, disruption of
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circadian rhythms, which occurs during shift work and social
jetlag, is associated with an increased risk of chronic diseases
such as type II diabetes, various cancers, and neurodegen-
erative disorders (33, 64). Understanding the cellular clock
mechanism and how it achieves the temporal coordination of
cell biology is, therefore, an important biomedical research
objective.
Many of the individual ‘‘clock genes’’ and proteins that
contribute to the fidelity of cellular timekeeping have been
identified, and are believed to function in a delayed gene
expression feedback loop whereby complexes containing the
transcription factor BMAL1 activate the expression of period
(1/2) and cryptochrome (1/2) genes, as well as other ‘‘clock-
controlled genes,’’ such as the antioxidant regulator NRF2
(24, 54, 59). The encoded PER and CRY proteins form in-
hibitory complexes that eventually repress BMAL1-
containing complex activity. The kinetics of this feedback
inactivation are post-translationally regulated to give rise to
persistent oscillations in the expression of clock and clock-
controlled genes that occur with a period of *24 h. The
precise cascade of molecular mechanisms that determines the
period of these oscillations is incompletely understood (49),
though it certainly involves the regulation of clock protein
activity and stability by conserved kinases such as casein
kinase 1d/e (43, 44). Various accessory feedback loops con-
tribute to the fidelity and amplitude of circadian gene ex-
pression [e.g., (5, 42, 58)], whereas changes in circadian
phase are effected by extracellular cues acting through sev-
eral different signaling mechanisms (e.g., glucorticoid re-
ceptor, growth factor and G-protein receptor signaling) to
stimulate acute changes in clock protein expression via in-
tracellular signal transduction cascades (7, 8, 22, 65, 68).
Complicating this picture are recent observations that
metabolic and redox pathways continue to exhibit circadian
regulation in the absence of rhythmic clock gene expression
(50, 51), suggesting the existence of an underlying post-
transcriptional timekeeping mechanism [reviewed in ref.
(56)]. Most notably, levels of redox co-factors and the abun-
dance of over-oxidized peroxiredoxin (PRX-SO2/3) exhibit
circadian regulation in isolated human and mouse erythro-
cytes (17, 51), which are naturally anucleate and, therefore,
cannot be dependent on cycling clock gene transcription.
Rhythms of PRX-SO2/3 and redox balance have been reported
in vivo, as well as in cultured tissues and cells (27, 37), and
also in other phylogenetic groups (4, 12, 32, 34, 46, 80). In
addition, although PRX itself plays no timekeeping role (16),
the activity of several clock proteins has been suggested to be
redox sensitive (47, 57, 70, 81). Moreover, nuclear translo-
cation of the antioxidant regulator NRF2 exhibits ultradian
and circadian rhythms (54, 78), and SIRT1-mediated deace-
tylation of certain clock proteins is reported to be dependent
on rhythmic availability of NAD+ (53, 58).
These observations suggest the possibility that redox-based
oscillations may constitute a bona fide and conserved mecha-
nism of the cellular clock in eukaryotes: a compelling hypoth-
esis proposing that an as-yet uncharacterized post-translational
oscillation in metabolism and redox balance reciprocally regu-
lates clock gene expression to determine the period of the cel-
lular circadian clock (60). Conversely, however, it is equally
plausible that redox and metabolic rhythms are simply post-
translational outputs of cellular clock function, and thus ir-
relevant to the timekeeping mechanism. A third possibility is
that changes in metabolism and redox balance constitute a
non-essential auxiliary cellular clock mechanism. In this
case, they would be rhythmically regulated, with transient
changes in metabolic activity and/or redox balance being
competent to regulate the amplitude and phase of circadian
gene expression, but not required to oscillate for the cellular
timekeeping mechanism to function.
To distinguish between these three models, we used phar-
macological and genetic approaches to perturb primary meta-
bolic pathways and cellular redox balance, thereby assessing the
causal relationships between cellular timekeeping and redox/
metabolism. We found not only evidence for cell-autonomous
circadian regulation of primary metabolism but also that inhi-
bition of glycolysis alone had no major effect on the cellular
clock.We further observed that the amplitude and phase of PER
protein expression is sensitive to redox balance and oxidative
pentose phosphate pathway (PPP) activity, but that the period of
oscillation was essentially insensitive to these perturbations.
Our data indicate that previously observed oscillations in cel-
lular redox state are not required for the cellular clock to
function, since the period of oscillation is robust against severe
chronic oxidative as well as reductive stress.
Finally, we found that pulses of physiologically relevant
concentrations of H2O2 elicited phase-dependent phase
shifts, which strongly correlated with immediate changes in
the expression level of the PER2 clock protein, providing a
mechanistic basis for understanding how transient redox
signals may contribute to cellular clock regulation under
more physiological settings. We, therefore, conclude that
redox signaling is not essential to the cellular timekeeping
mechanism (i.e., it is not a state variable of the oscillation) but
that it does function as both an input and an output of the
circadian clockwork.
Results
Cell-autonomous rhythms of glucose catabolism
drive rhythmic NAD(P)H generation
Circadian rhythms in the levels of several redox co-factors,
primary metabolites, and the abundance of over-oxidized
PRX have been observed in several cultured mammalian cells
and tissues, as well as in vivo (17, 51, 53, 56). Here, we set out
to test the relationship between circadian timekeeping, redox
balance, and metabolic flux (Supplementary Fig. S1; Sup-
plementary Data are available online at www.liebertpub.com/
ars), by using a primary cellular model: immortalized, but
non-transformed, fibroblasts derived from the lung tissue of
Innovation
Circadian rhythms in primary cellular metabolism and
redox state have previously been proposed to play a role
in the timekeeping mechanism. We tested this hypothe-
sis, and found that although primary metabolism and
redox signaling can function as both an input and an
output of the cellular clockwork, they do not determine
its period and are, thus, unlikely to constitute essential
mechanistic timekeeping components. Importantly, we
do find that PER2 stability is acutely sensitive to H2O2
transients, implicating this clock protein as a circadian
effector of redox signaling.
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adult PER2::luciferase (LUC) mice (29, 75, 79). The attrac-
tion of this model is that fibroblasts contact-inhibit to form
confluent, quiescent cell monolayers that express robust cir-
cadian rhythms in bioluminescence due to the fusion of the
firefly LUC open reading frame at the 3¢-end of the core clock
gene Per2. This fusion allows us to longitudinally follow
PER2::LUC activity, a well-characterized and faithful re-
porter of PER2 protein levels, and thus clock activity (29, 75,
79). Indeed, in this system, both PER2::LUC and PRX oxi-
dation show overt circadian oscillations (Fig. 1A and Sup-
plementary Fig. S2F). To validate key observations from this
model, we also employed stable human and mouse cell lines
expressing other well-established reporters of circadian tran-
scriptional cycles. These are presented as Supplementary
Figures.
Cytosolic redox homeostasis is a dynamic equilibrium that
is ultimately dependent on the rate of production of oxidizing
reactive oxygen species (ROS) and reducing equivalents in
the form of NADPH (and to a lesser extent NADH), which
are primarily determined by rates of primary metabolic flux
(23). Isotopic labeling of glucose is a sensitive method for the
measurement of metabolic flux, since pathway fluxes can be
interpolated from the abundance and label distribution of
glycolytic end products, lactate and pyruvate (13, 18, 19, 25).
In longitudinal assays of PER2::LUC fibroblasts, continu-
ously perfused with media containing labeled glucose and
luciferin, we detected a rhythm in total media lactate and
pyruvate production (measured by liquid chromatography
coupled to mass spectrometry [LC-MS] analysis) that peaked
approximately at the same time as PER2 (Fig. 1A). This
correlated with an increase in media acidification (extracel-
lular acidification rate [ECAR]: reporting glycolytic rate) and
respiration (oxygen consumption rate [OCR]: reporting re-
spiratory rate) measured by extracellular flux analysis, indi-
cating that primary metabolic flux is, indeed, clock regulated
and peaks during what corresponds to the active phase in vivo
(Fig. 1B), and in agreement with prior indications in the
human U2OS cell line (2).
We then investigated whether circadian glucose catabo-
lism is actively regulated in our PER2::LUC fibroblasts. At
the beginning of glucose catabolism, there occurs a branch
FIG. 1. Cell autonomous circadian regulation of pri-
mary metabolism in mouse fibroblasts. (A) Liquid chro-
matography coupled to mass spectrometry analysis of
perfused cell media reveals a significant variation (by co-
sinor analysis) in glycolytic end products (lac + pyr, lactate
and pyruvate), peaking at the same time as PER2::LUC
(molecular clock reporter) recorded from the same cultures
simultaneously (mean – SEM). (B) Extracellular flux anal-
ysis over a circadian cycle indicates a significant variation in
primary metabolism, in the same phase as peak activity of
PER2::LUC bioluminescence recorded from parallel cul-
tures (mean– SEM, one-way ANOVA). (C) Schematic of
primary metabolic pathways, indicating the activity of the
drugs used throughout this article. The validation of path-
way inhibition by these inhibitors is shown in Supplemen-
tary Figure S2. ANOVA, analysis of variance; ECAR,
extracellular acidification rate; ETC, electron transport
chain; LUC, luciferase; OCR, oxygen consumption rate;
PPP, pentose phosphate pathway; SEM, standard error of the
mean; TCA, tricarboxylic acid cycle.
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point that directs glucose-6-phosphate toward glycolysis
(producing ATP and NADH), or the PPP, which produces re-
ducing equivalents in the oxidative portion (NADPH) as well
as biosynthetic intermediates during the non-oxidative portion
(Fig. 1C). Using 13C-based flux analysis (Supplementary
Fig. S1), we tested whether dynamic rerouting of metabolic
flux occurred between glycolysis and the PPP over the circa-
dian cycle.
We found no significant rhythm in the relative proportion
of glucose catabolism between the two pathways (Supple-
mentary Fig. S2A). This suggests that any rhythm in the
NADP+:NADPH redox couples (51, 61) must occur pas-
sively, as a function of changes in co-factor oxidation and/or
overall changes in glucose utilization. We also detected no
significant rhythm in the ratio of lactate:pyruvate (Supplemen-
tary Fig. S2A), which is reflective of the free NAD+:NADH
ratio (19), indicating that previously reported rhythms of
NAD+:NADH may not represent the freely available pool.
Critically, however, our observations indicate that the rate of
production of NADH and NADPH shows a circadian rhythm
in these cells, which is the greatest around the same phase as
peak PER2 levels. This means that the generation of reduc-
tive potential is highest at the same time as maximal mito-
chondrial activity, based on our OCR measurements.
Glucose catabolism primarily determines the amplitude
of circadian gene expression, not its period,
via the PPP
We next asked whether rhythmic glucose catabolism and
NAD(P)H production were, in fact, required for cellular
timekeeping, or might instead be a consequence of it. We
treated cells with 2-deoxyglucose (2DG), an anti-metabolite
that is phosphorylated by hexokinase to produce 2DG-6-P,
which dose dependently inhibits downstreamflux through both
glycolysis and the PPP (10) (Figs. 1C and 2D, and Supple-
mentary Fig. S2B–E). We observed that 2DG elicited a pro-
found and dose-dependent suppression of PER2::LUC rhythms
(Fig. 2A, B, and E), whereas effects on period were small,
inconsistent, and difficult to quantify reliably due to rapid
damping. Oscillations recovered gradually on changing cells
back into normal (2DG-free) media (Fig. 2A), indicating that
the damping of PER2 rhythmswas not due to cytotoxicity, with
the slow recovery presumably being attributable to intracel-
lular 2DG-6-P accumulation.We observed very similar results
in additional cell lines (humanU2OS cells and mouse NIH3T3
cells) expressing two different bioluminescent reporters for
clock gene transcription (Per2:LUC and Bmal1:LUC, re-
spectively) (Supplementary Fig. S3). Importantly, ATP levels
in cells treated with 2DG for 3 days were not decreased
(Fig. 2C) and actually increased at one concentration, as also
occurs during Mg2+ depletion (28); and 2DG treatment had
only a very modest effect on bioluminescence levels in cells
expressing firefly LUC under the constitutive SV40 promoter
(Fig. 2E and Supplementary Fig. S3B, E). In addition, we ob-
served that depletion of glucose from the media did not phe-
nocopy the effects of 2DG, instead eliciting a slight but
significant increase in circadian period (Fig. 2F, G), as previ-
ously (40). We, therefore, conclude that 2DG treatment im-
pacts clock gene amplitude through a differentmechanism than
glucose starvation, and it is not an artifact of LUC inhibition,
ATP depletion, or general inhibition of gene expression.
We next asked whether the effect of 2DG treatment might
be attributable to its action on the glycolytic pathway or PPP.
Genetic knockouts of glycolytic and PPP enzymes are cyto-
toxic and so to accomplish this we employed transient RNAi
knockdown of either glucose-6-phosphate dehydrogenase
FIG. 2. 2DG reversibly dampens circadian rhythms in
mouse fibroblasts. (A) 2DG immediately dampens PER2::
LUC rhythms (left panel), which gradually recover on a change
to 2DG-free media (black arrows, right panel); the ratio of
glucose and 2DG concentrations, respectively, is indicated in
square brackets. Mean–SEM of representative experiments
are plotted; statistical test: circadian fit versus straight line. (B)
Effect of 2DG treatment on PER2::LUC amplitude is dose
dependent, whereas the effect on period is not (mean–SEM,
one-way ANOVA for each is reported). (C) 2DG treatment
does not significantly decrease cellular ATP levels after 72 h
(mean–SEM, replicate number, and Holm-Sidak p-values vs.
control). (D) 2DG significantly reduces glycolytic flux (ECAR;
mean–SEM, replicate number, and Holm-Sidak p-values vs.
control). (E) Comparison of bioluminescence from 2DG-
treated PER2::LUC and SV40:LUC fibroblasts at 24 h
(mean–SEM, two-way ANOVA for 2DG vs. reporter inter-
action is reported). (F) Effect of glucose depletion on
PER2::LUC rhythms (representative concentrations, mean–
SEM). (G) Effect of different glucose concentrations on cir-
cadian period and PER2::LUC bioluminescence at 24 h (one-
way ANOVA p-values for each are reported). *p< 0.05,
****p< 0.0001, ns, p> 0.05. 2DG, 2-deoxyglucose.
4 PUTKER ET AL.
D
ow
nl
oa
de
d 
by
 8
0.
6.
11
2.
99
 fr
om
 o
nl
in
e.l
ie
be
rtp
ub
.co
m
 at
 0
8/
14
/1
7.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
(G6pdh) or phosphoglucose isomerase (Gpi), the enzymatic
gatekeepers of the PPP and glycolytic pathways, respectively.
Although cellular levels for both proteins were reduced by
*50%, we observed that only knockdown ofG6pdh elicited a
significant reduction in PER2 levels, whereas Gpi knockdown
did not (Fig. 3). This was accompanied by a significant but
small shortening of period by 0.6– 0.1 h (t-test, p= 0.001),
which we do not consider to be noteworthy (see the section
‘‘Materials and Methods’’).
The activity and abundance of essential metabolic en-
zymes is typically much greater than cellular demand, ex-
plaining why reduced enzyme levels might not elicit as strong
an effect as 2DG treatment, and we, therefore, sought to test
whether the greater sensitivity of PER2 oscillations to PPP
over glycolytic activity, indicated by genetic knockdown,
could be validated by using pharmacological approaches. We
found that inhibitors of the oxidative PPP (flavoprotein in-
hibitor diphenyleneiodonium [DPI; (62)] and G6PDH in-
hibitor dehydroepiandrosterone [DHEA; (31)] consistently
phenocopied the effect of 2DG in all three cellular models
(Fig. 4A–E and Supplementary Fig. S4A, B, F, and G),
whereas selective inhibition of the non-oxidative PPP (oxy-
thiamine; Fig. 4F, G, and Supplementary Fig. S4C–E) did
not. Since DPI and DHEA belong to different classes of drugs
and inhibit PPP flux by different mechanisms, our results
suggest that PPP flux can regulate the level of cellular clock
gene expression. In contrast, we found that selective,
FIG. 3. G6PDH activity regulates the amplitude of
circadian rhythms in mouse fibroblasts. Western blot
analysis (A, B) and its quantification (C, D) from cells si-
lenced for Gpi or G6pdh (mean – SEM, Student’s t-test). (E)
Effect of RNAi silencing of Gpi and G6pdh on PER2::LUC
rhythms (mean –SEM). (F) Silencing of G6PDH but not of
GPI results in decreased clock protein amplitude, measured
at the second peak of bioluminescence (mean – SEM, Stu-
dent’s t-test). *p < 0.05; **p < 0.01, ns, p> 0.05. G6PDH,
glucose-6-phosphate dehydrogenase; GPI, phosphoglucose
isomerase.
FIG. 4. PPP inhibition reversibly dampens circadian
rhythms in mouse fibroblasts. Effect of DPI (flavoprotein
inhibitor) (A, B) and DHEA (G6PDH inhibitor) (C, D) on
PER2::LUC rhythms. Left panels show traces of represen-
tative concentrations (mean – SEM). Black arrows indicate
change to drug-free media. Right panel shows dose-
dependent effects of drug treatments (mean – SEM, one-way
ANOVA p-value for each parameter is reported). (E) DPI
and DHEA do not reduce glycolytic flux (replicate numbers
and Holm-Sidak p-values are reported). (F) Effect of oxy-
thiamine (oxyth, transketolase inhibitor) on PER2::LUC
rhythms (representative mean – SEM). (G) Effect of oxy-
thiamine treatment on PER2::LUC amplitude and period
(one-way ANOVA p-value for each parameter is reported).
*p< 0.05, ns, p> 0.05. DHEA, dehydroepiandrosterone;
DPI, diphenyleneiodonium.
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established inhibitors of different glycolytic enzymes
(GAPDH inhibitor koningic acid [KA; (66)] and pyruvate
analog 3-bromopyruvate (55) did not elicit a decrease in the
amplitude of clock gene expression and evoked small, in-
consistent effects on circadian period in the three different
and independent cellular models that were employed (Fig. 5
and Supplementary Fig. S5). Importantly, the action and se-
lectivity of the glycolytic versus PPP flux inhibitors was
confirmed by LC-MS-based metabolic tracing (Supplemen-
tary Fig. S2B–E), where we confirmed major effects of each
glycolytic and PPP inhibitor on flux through the PPP and
glycolysis, respectively, as well as effects on NADH avail-
ability and glucose utilization (Supplementary Fig. S2B–E).
Thus, genetic and pharmacological evidence suggests that
the amplitude of circadian gene expression oscillations is
differentially sensitive to oxidative PPP compared with gly-
colytic activity. Critically, the effect of severe and chronic
metabolic inhibition on circadian period was verymodest and
also inconsistent between our different cellular models. This
is hard to reconcile with models in which metabolic/redox
oscillations play essential and conserved roles within the
circadian timekeeping mechanism, but it does suggest that
PPP activity may have an accessory role in regulating clock
amplitude. We, therefore, wondered how PPP inhibition
might impact circadian gene expression cycles.
Redox balance primarily affects clock gene expression
amplitude, not circadian period
A potential consequence of a sustained reduction in flux
through the oxidative PPP flux is a reduction in the rate with
which NADPH can be regenerated from NADP+. In turn, this
would be expected to induce a sustained oxidation of cellular
redox balance. Correspondingly, we found that 24 h treat-
ment with 2DG significantly increased the cellular NADP:
NADPH ratio (Supplementary Fig. S6A), indicating a more
oxidized cellular environment; and that reducing reagent 2-
mercaptoethanol (2ME) transiently attenuated the effect of
2DG on PER2 amplitude (Supplementary Fig. S6B). To test
whether chronic perturbation of cellular redox homeostasis
might constitute the means whereby PPP inhibition impacts
the amplitude of circadian gene expression, we incubated
cells with a range of concentrations of 2ME or glucose oxi-
dase (GOX, catalyzing the oxidation of glucose to form
d-glucono-1,5-lactone and the continuous production of H2O2).
We observed that the reducing treatment elicited a dose-
dependent and reversible reduction in the amplitude of cir-
cadian gene expression (Fig. 6A top, B and Supplementary
Fig. S6C), whereas the oxidizing treatment initially increased
and then reduced the amplitude of clock gene oscillations
(Fig. 6A, C). We further noted that there was a significant
interaction between circadian amplitude and the circadian
phase at which the redox treatment occurred: Cells were less
sensitive to 2ME treatment that began at the trough of PER2
expression (CT0) than at its peak (CT12). Conversely,
treatments with all but the highest levels of GOX evoked
greater increases in the subsequent amplitude of PER2::LUC
oscillations, when added at CT0, than was observed when
treatments commenced 12 h later. Although we did see a
significant interaction between the period of oscillation and
phase of treatment with both 2ME and GOX ( p < 0.0001,
two-way analysis of variance), the effect size was very small
FIG. 5. Circadian rhythms in mouse fibroblasts are in-
sensitive to glycolytic inhibition. (A). Left: effect of KA
(GAPDH inhibitor) on PER2::LUC rhythms (mean–SEM).
Right: effect of KA treatment on PER2::LUC amplitude and
period (mean–SEM, one-way ANOVA p-value for each pa-
rameter is reported). (B). Left: effect of 3-Br-Pyr (pyruvate
analogue preventing flux through glycolysis) on PER2::LUC
rhythms (representative mean–SEM). Right: effect of 3-Br-
Pyr treatment on PER2::LUC amplitude and period (mean–
SEM, one-way ANOVA p-value for each parameter is re-
ported). (C) Effect of KA treatment on glycolytic flux (un-
paired t-test p-value and replicate number are reported). (D)
Effect of 3-Br-Pyr treatment on respiration (two-way ANOVA
p-value and replicate number). 3-Br-Pyr, 3-bromopyruvate;
Anti A, antimycin A; KA, koningic acid; ROT, rotenone.
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(<7% control) compared with the effect on amplitude. GOX
and 2ME treatment, respectively, impose chronic oxidative
and reductive stresses, which are well outside the normal
range of cellular redox homeostasis. Our observation,
therefore, suggests that the period of oscillation is quite ro-
bust against these ‘‘sledgehammer’’ treatments.
Redox signals regulate the cellular clock
via PER2 stability
The phase-dependent effects of reducing or oxidizing the
cellular redox environment indicated that redox signaling
might play a bona fide role in regulating clock protein activity,
as has previously been proposed in other model organisms
such as Neurospora crassa (80). We tested this hypothesis by
using H2O2, the putative secondmessenger in redox signaling
relays (23, 35). Cells were treated with vehicle or a bolus of
H2O2, every 3 h over a complete circadian cycle, and the
effects on the subsequent rhythm were analyzed (Fig. 7 and
Supplementary Figs. S7 and S8). We observed no consistent
changes in circadian period, whereas we did observe phase
shifts that conformed to a classic circadian phase response
curve, with delays of *2 h occurring around CT12 (peak
PER2) and advances of*2 h occurring over a smaller win-
dow around CT0 (Fig. 7B). Although we also observed a
phase-dependent and significant change in amplitude
(Fig. 7C), we observed no correlation between the phase shifts
and the subsequent amplitude of PER2 expression (R2 = 0.05,
data not shown). Interestingly, a strong correlation was ob-
served between the acute decrease in total PER2::LUC levels
occurring immediately after H2O2 addition and themagnitude
and direction of the phase shift elicited (R2 = 0.75) (Fig. 7D).
The phase shift occurred in a dose-dependent manner, with
maximum effect occurring at ‡0.5mMH2O2, and it remained
significant at physiologically relevant concentrations of H2O2
(Fig. 7E); whereas control treatments with 2ME elicited no
such effect (Fig. 7F). These results suggest a possible physi-
ological role for H2O2 signaling: to relay extracellular (e.g.,
growth factor) or intracellular (e.g., mitochondrial metabolic)
cues to the cellular clock and alter its phase, since PER2 is a
bona fide state variable of the cellular clockwork (21).
Acute changes in the expression of PER2 protein abun-
dance are an accepted mechanism by which circadian phase
shifts occur (both in cells and in vivo) (1, 6, 8, 9, 21, 72), and
our data, thus, suggest PER2 to be a functional circadian
effector of redox signaling in mammalian cells. To confirm
that the drop in LUC signal was a true report of decreased PER2
protein levels, we used immortalized fibroblasts isolated from
knock-in transgenic mice expressing the PER2::VENUS fu-
sion protein (73), as the VENUS-tag allows for clear quan-
tification of PER2 by Western blot using an anti-GFP
antibody. At the peak of PER2 expression (i.e., CT12), we
treated the cells with H2O2 or the disulfide-inducing reagent
diamide and analyzed protein levels by immunoblotting.
Similar to the results of our longitudinal assays (Fig. 7A and
Supplementary Fig. S7), we observed that PER2 levels were
significantly reduced after an acute oxidative insult (Fig. 8A).
This reduction was dose dependent and correlated well with
the phase shift reported in Figure 7E.
The observed reduction of PER2 protein levels could be
either the effect of a temporary inhibition of translation or the
result of increased PER2 protein degradation. We therefore
compared the rate of PER2 decay on redox stress with that of
cells treated with a saturating concentration of translation
inhibitor cycloheximide (CHX) and found that both H2O2
and diamide induced a greater decrease in PER2 levels than
CHX alone, indicating that PER2 degradation is increased on
an oxidative insult (Fig. 8B). This result was recapitulated
with PER2::LUC fibroblasts, where we observed that H2O2
decreased PER2 acutely, even in the presence of saturating
CHX (Supplementary Fig. S9).
Discussion
We investigated the causal relationships between redox
metabolism and circadian gene expression cycles in cultured
mammalian cells. In keeping with previous observations, we
FIG. 6. Redox balance regulates the amplitude of cir-
cadian rhythms in mouse fibroblasts. (A) Effect of chronic
GOX and 2ME treatment on PER2::LUC rhythms, with
treatment beginning at two opposite circadian phases (CT,
CT0 or CT12) (representative mean – SEM are shown
[n = 4]). (B) Effect of 2ME and (C) GOX treatment on
PER2::LUC amplitude and period (two-way ANOVA p-
values for amplitude vs. concentration effect [n = 4]). 2ME, 2-
mercaptoethanol; CT, circadian time; GOX, glucose oxidase.
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observed compelling evidence that total glucose catabolism
is circadian regulated (2, 30, 38), meaning that the rate of
glycolytic NADH production and PPP-mediated NADPH
production is also rhythmic. We found no evidence for active
cell-autonomous circadian redistribution of metabolic flux
between the NADH- and ATP-producing glycolytic pathway
and the NADPH-producing PPP, suggesting that this cannot
be a general feature of the circadian clock in mammalian
cells. It seems more likely that, in the absence of oxidative or
reductive stress, any rhythm in steady-state redox co-factor
levels arises passively, as a consequence of rhythms in overall
glucose catabolism and/or cofactor consumption. We should
mention, however, that despite our repeated efforts, we have
been unable to find evidence for overt circadian regulation of
glutathione redox potential, the NAD+/NADH ratio, or the
NADP+/NADPH ratio in any of the cell culture models em-
ployed in this study. This indicates that although PRX-SO2/3
rhythms may result from a cell-autonomous oscillation in
cellular ROS production and/or redox potential, the oscilla-
tion’s amplitude lies beneath the threshold of detection in our
cell models, it does not appear to have any major role in the
determination of circadian period, and it is, therefore, unlikely
to constitute an essential timekeepingmechanism. Indeed, it is
plausible that PRX-SO2/3 rhythms result from the rhythmic
proteasomal degradation of over-oxidized PRX, as has been
suggested in mouse erythrocytes (13).
Our data indicate that circadian gene expression is not
affected by circadian oscillations in (NADH-generating)
glycolytic flux, whereas chronic PPP inhibition and per-
turbation of redox balance primarily determine the ampli-
tude of oscillation and not its period. This again suggests
that circadian oscillations in redox homeostasis and pri-
mary metabolism do not play any essential role in the cel-
lular timekeeping mechanism itself, whereas there exists a
permissive range of PPP activity and redox state, beyond
which clock gene expression rhythms cannot be sustained.
We observed that the clock in U2OS cells, in particular, was
profoundly resilient to reductive stress, with concentrations
of 0.5mM 2ME eliciting minimal effects on the amplitude
and period of circadian rhythms in transcription (Supple-
mentary Fig. S6D). We also observed no effect on circadian
rhythms of the NRF2 activator sulforaphane or NRF2 RNAi,
nor did NRF2 levels change consistently during PPP inhibi-
tion (Supplementary Fig. S10) (54). Again, a timekeeping
FIG. 7. Acute H2O2 treatment elicits phase-dependent
PER2 degradation and circadian phase shifts in mouse
fibroblasts. (A) Effect of an acute H2O2 bolus (1mM final,
black arrow) on PER2::LUC rhythms (representative
mean – SEM are shown). (B) Phase response curve to H2O2
treatment at indicated CT (mean – SEM, one-way ANOVA
p-value). (C) Effect of H2O2 bolus at indicated CT on sub-
sequent peak PER2::LUC (mean–SEM, one-way ANOVA
p-value, and replicate numbers are reported). (D) Correlation
between the immediate decrease in PER2::LUC biolumi-
nescence after the H2O2 bolus and the subsequent circadian
phase shift (mean– SEM, correlation statistics). (E) Phase
shift induced by an acute H2O2 bolus at CT12 occurs at
physiologically relevant H2O2 concentrations and is dose
dependent up to 1mM (mean – SEM, one-way ANOVA p-
value). (F) No phase shift is induced by an acute 2ME bolus
at CT12 (mean – SEM, one-way ANOVA p-value).
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mechanism that is effectively insensitive to chronic reductive
stress is not readily compatible with redox oscillations play-
ing some essential and conserved role in the cellular clock-
work.
Because PPP inhibition and chronic redox disruption
phenocopied the effect of 2DG on clock gene expression
rhythms in three independent mammalian cell lines expres-
sing three different bioluminescent reporters, we think it
plausible that PPP/redox regulation of the amplitude of clock
gene expression rhythms may reflect a general feature of how
redox signals are integrated into the mammalian cellular
circadian clockwork. We do note, however, that our findings
using three different PPP inhibitors (2DG, DPI, DHEA) differ
markedly from the reported effect of the niacin antagonist,
6-aminonicotinamide (6AN), which increases circadian period
in (transformed) U2OS cells when employed at millimolar
concentrations (61). 6AN becomes incorporated into NAD+
and NADP+ antimetabolites (6ANAD and 6ANADP), and
thereby inhibits a wide range of NAD(P)+-dependent cellular
processes (74). Unlike in U2OS cells however, we found that
6ANdid not elicit period lengthening of PER2::LUC rhythms in
non-transformedmouse fibroblasts (Supplementary Fig. S11). It
is, therefore, possible either that the clock in these trans-
formed cells, which rely heavily on Warburg metabolism
(41), is more sensitive to 6AN or that the action of 6AN on the
circadian clock is not specific to inhibition of the PPP.
In (non-transformed) mouse fibroblasts, we observed a
phase-dependent and opposite sensitivity to reductive and
oxidative stress in terms of the subsequent amplitude of clock
gene expression rhythms. Specifically, cells were more tol-
erant to oxidative stress around the peak of PER2 expression
(CT12), when combined glycolytic and PPP flux was great-
est, and more tolerant to reductive stress around the nadir of
PER2 expression, when the lowest rates of carbohydrate
metabolism were observed. This establishes a functional
consequence for circadian regulation of primary metabolism
and redox balance that could have interesting chronother-
apeutic applications (52). For example, in the context of pro-
oxidant chemotherapies, onemight anticipate that milder side
effects will be observed in non-tumor cells (expressing nor-
mal circadian rhythms) when treatments coincide with the
peak of PER2 expression, that is, occurring around antici-
pated dawn in humans (3, 20).
Circadian rhythms in the abundance of over-oxidized
PRXs have been interpreted to indicate the existence of an
underlying ‘‘redox oscillator’’ (60, 76). Our data strongly
support the interpretation that redox signaling can elicit phase
shifts, that NAD(P)H generation is rhythmic, and that the
cellular redox environment appears to regulate the amplitude
of circadian gene expression. However, our observations also
clearly indicate that cellular timekeeping is remarkably ro-
bust against perturbation of redox balance in terms of the
period of oscillation. We therefore conclude that our obser-
vations are most consistent with the third model that we in-
troduced: that any circadian variations in redox balance are a
cellular clock output, likely to result at least partially from
rhythmic flux through primary metabolic pathways, but are
not essential to cellular timekeeping. Moreover, redox sig-
naling is competent to modulate the level of PER protein
expression and thus, acute changes in redox balance can elicit
phase-dependent circadian phase shifts. If our interpretation
is correct, this would establish redox balance as an auxiliary
feedback loop, akin to a zeitnehmer (63), a cellular system
that is rhythmically regulated and can regulate the rhythm but
is not essential to the timekeeping mechanism itself. Future
work will need to test the potential physiological relevance of
our findings, and the molecular mechanism that facilitates
such rapid PER2 degradation in response to acute increases in
intracellular H2O2.
Materials and Methods
Mammalian cell culture
Primary fibroblasts isolated from lung tissue (71) of adult
PER2::LUC male mice [kindly provided by J. S. Takahashi
(UT Southwestern, United States) (79)] and PER2::VENUS
fibroblasts (kindly provided by M. Hastings [MRC LMB,
United Kingdom (73)] were cultured as previously described
(48) and immortalized by serial passage (77). U2OS and
NIH3T3 cells were obtained from ATCC and used to gen-
erate transcriptional LUC-reporter cell lines as previously
described (15, 48), and they were not passaged above 30
times. All cells were confirmed as being free of mycoplasma.
Silencing experiments
Cells were seeded in 24-well plates at a density of 1· 105/
well and transfected with HiPerFect transfection reagent
(Qiagen) by using the manufacturer’s recommended reverse
transfection protocol. Media were changed after 20 h, and cells
were allowed to grow to confluence for a further 48 h. Cells
were then synchronized by using 100 nM dexamethasone for
2 h, changed into air medium and bioluminescence was
FIG. 8. Acute H2O2 and diamide treatment induce
rapid PER2 degradation. (A) Western blot analysis of cell
lysates of PER2::VENUS cells treated with H2O2 (60lM–
1mM) or diamide (250lM) for 15min at the expected peak
of PER2 expression. The graph depicts the PER2::VENUS
levels relative to tubulin expression. (B) Experiment as in
(A). Effects of acute oxidative stress (H2O2 or 250 lM di-
amide) for 15min, at the normal PER2 peak, on PER2
stability, in the presence or absence of the inhibitor of
protein synthesis CHX (10 lM). A similar experiment as-
sessing PER2::LUC bioluminescence can be found in Sup-
plementary Figure S9. CHX, cycloheximide.
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recorded as described later. We observed more rapid damping
and increased baseline bioluminescence in recently transfected
cells using this protocol than in control cells of other experi-
ments, which was controlled for in our analyses. In light of
prior observations, this was most likely associated with an in-
creased rate of intercellular desynchronization (48, 75). To
assay for protein expression, parallel plates were lysed (in
triplicate) for immunoblotting 96h after transfection.
Bioluminescence recordings
Bioluminescence recordings under static conditions were
performed in 20mM HEPES-buffered air medium (48) sup-
plemented with 2% B-27 (Life Technologies; 50 · ), 0.3 or
1mM luciferin (Biosynth AG; 0.3mM for U2OS cells and
1mM for fibroblasts), 1· glutamax (Life Technologies),
100U/ml penicillin/100 lg/ml streptomycin, and 10% Fe-
talCloneTM II or III serum (HyCloneTM; II for U2OS and III
for fibroblasts). Osmolality was adjusted to 350mOsm with
NaCl. Before each experiment, cells were synchronized by
using temperature cycles (12 h 32C–12 h 37C) for at least
3 days. Experiments were begun immediately after a medium
change from culture medium to air medium, with or without
drug as indicated (at 0 h). Vehicle treatments were performed
with water, dimethyl sulfoxide (DMSO), or ethanol as ap-
propriate, with the final concentration of solvent never being
more than 0.3% DMSO or 0.1% ethanol. Bioluminescence
activity was measured in a Lumicycle (Actimetrics), an
LB962 plate reader (Berthold Technologies), or an ALLI-
GATOR (Cairn Research). Lumicycle and plate reader
measurements are reported as counts per second, whereas
ALLIGATOR measurements are reported as relative lumi-
nescence units. For technical reasons, the bioluminescence
data presented in Figure 1A and Supplementary Figure S2A
were normalized to the first peak of PER2::LUC biolumi-
nescence to account for differences in the efficiency of light
detection, resulting from variable distances of microfluidic
devices from the camera lens.
Metabolic labeling strategy
Classically, either singly or doubly 13C-labeled glucose
has been used to investigate flux through the PPP (13, 25).
Glucose passing though the PPP loses its first carbon mole-
cule as CO2 during the oxidative phase, after which re-
arrangements in the non-oxidative PPP produce differently
labeled metabolites to those from glucose that has passed
solely through glycolysis, allowing for calculation of PPP
flux. However, 13C may also be present at additional glucose
carbons due to its natural abundance (*1%) or due to im-
purities from the enrichment process. This has the potential to
introduce error into calculations of the relative fluxes be-
tween glycolysis and the PPP by using either the singly or
doubly labeled method. To avoid this problem, we utilized
1,2,3-13C-labeled glucose as our labeled substrate. Metabo-
lism of 1,2,3-13C glucose through either glycolysis or the
PPP produces fully 13C-labeled or completely unlabeled (12C)
3-carbon metabolites (lactate and pyruvate, Supplementary
Fig. S1), which may serve as substrates for mitochondrial
respiration or are exported into the cell culture media. 13C and
12C lactate/pyruvate are produced in different ratios de-
pending on which metabolic pathways they have passed
through: Flux through glycolysis produces a 1:1 ratio of 13C-
labeled to 12C-unlabeled product, whereas flux through the
PPP produces a ratio of 2:3 (Supplementary Fig. S1). Ana-
lysis of the ratios of these two metabolites allows for accurate
determination of the relative metabolic fluxes between the
two pathways. This method is not affected by three-carbon
metabolites produced by other pathways as a result of im-
purities in the labeled glucose, as these will be singly or
doubly labeled, allowing for more accurate determination of
primary metabolic flux. For analysis of perfusion time
courses, we only consider samples that were collected after
the levels of 1,2,3-13C-glucose in the perfusate had attained a
stable baseline, to avoid any potential confounding effects
that might otherwise be introduced by unlabeled glucose
from the media in which the cells were previously cultured.
Perfusion recordings
Recordings under perfusion were carried out by using cells
seeded in micro-slide 0.6 (Ibidi). Immediately before record-
ing, cells were changed into bicarbonate-buffered Dulbecco’s
modified Eagle medium (DMEM) containing 1 g/L d-glucose
and supplemented with 2% Fetalclone III serum, B-27,
glutaMAX, luciferin, penicillin, and streptomycin as for air
medium. Cultures were then placed at 37C, 5% CO2 in an
ALLIGATOR and bioluminescence was recorded while cells
were under continuous media perfusion at a rate of 50ll/h.
Media were kept at room temperature within 20ml BD Plas-
tipak syringes and were driven across the cells by using anNE-
1600 programmable syringe pump. Out-flow media were
collected on ice and, subsequently, snap frozen every 4 h.
Pharmacological perturbations
KA was supplied by 2BScientific. All other drugs and
chemicals were used in concentrations as indicated, and
they were from Sigma. DPI and carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone (FCCP) were dissolved
in DMSO, KA in EtOH, DHEA in MeOH, GOX in
phosphate-buffered saline, and 6AN and oxythiamine in air
medium. All other drugs were dissolved in H2O. We found
that NIH3T3 fibroblast cultures required 1mM mannose to
remain viable in the presence of 2DG [presumably to provide
a substrate for protein glycosylation (39)]. Similarly, we
found that U2OS cells required 10mM pyruvate to remain
viable in the presence of KA [presumably providing a sub-
strate for mitochondrial respiration to maintain ATP pro-
duction (26)]. The 3T3 and U2OS experiments and controls
reported in Supplementary Figure S3 and S5 only were,
therefore, performed with either mannose or pyruvate sup-
plementation, respectively. The non-transformed fibroblasts
that were used for experiments reported in main figures were
not so supplemented in any case.
ATP measurements
ATP measurements were performed as previously de-
scribed (28).
Extracellular flux analysis
Measurements of ECAR (a reliable proxy for glycolytic
rate) and rate of OCR (which correlates with cellular respi-
ration rate) were performed with a Seahorse XFe96 analyzer
(Agilent) by using the Seahorse XF Cell Mito Stress test and
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Glycolysis Stress Test Kits (Agilent). Cells were seeded in
Seahorse XF96 cell culture microplates, grown to confluence,
subjected to temperature cycles for 72 h, given a media
change, and incubated at constant 37C. Immediately before
each measurement, a plate was removed from the incubator;
media were then changed to Seahorse XF Media (Agilent)
and warmed to 37C on a 37C isothermal pad. Seahorse XF
Media were supplemented with 1% glutaMAX, and also
11mM glucose and 200lM pyruvate for those cells used with
the Mito Stress Test. Plates were calibrated with Seahorse XF
Calibrant (Agilent) before every test, as per the manufac-
turer’s instructions. Basal respiration and glycolysis is de-
termined before any drug treatment in cells but in the
presence of glucose. Maximal respiration is determined after
treatment with the proton ionophore FCCP. Maximal gly-
colytic capacity is determined after the addition of ATP
synthase inhibitor oligomycin.
Metabolic labeling sample preparation
Cells were perfused (as described earlier) with 1,2,3-13C
glucose substituted in place of unlabeled glucose. Outflow
media were snap frozen. Subsequently, samples were de-
frosted and centrifuged in a bench-top centrifuge at 4C, at
maximum speed for 5min. Fifty microliters of the resulting
supernatant was resuspended in 750ll extraction buffer
(375 ll methanol, 225 ll acetonitrile +150 ll H2O) and then
mixed at 1000 rpm for 15min at 4C in a ThermoMixer
(Eppendorf). Samples were then centrifuged again at 4C, at
maximum speed in a bench-top centrifuge for 10min, and the
resulting supernatant was transferred to a new vial and stored
at -80C until analysis by LC-MS.
Cell culture medium analysis by LC-MS
The LC-MS analysis was performed on a Dionex U3000
UHPLC system coupled to a Q ExactiveHybrid Quadrupole-
Orbitrap Mass Spectrometer (Thermo Scientific). The liquid
chromatography system was fitted with a SeQuant ZIC-
pHILIC column (150mm· 2.1mm. 3.5lm) and guard column
(20mm· 2.1mm 3.5lm) from Merck Millipore. The mobile
phase was composed of 20mM ammonium carbonate and
0.1% ammonium hydroxide in water (solvent A), and ace-
tonitrile (solvent B). The flow rate was set at 180 ll/min with
the following gradient: 0min 70% B, 1min 70% B, 16min
38%B, 16.5min 70%B, and a hold at 70%B for 8.5min. The
operator was blinded to the samples, which were randomized
to avoid bias due to machine drift. The acquired spectra were
analyzed using XCalibur Qual Browser and XCalibur Quan
Browser software (Thermo Scientific) by referencing to
commercially available compounds and an internal library of
compounds.
NADP+:NADPH ratio
Assays to determine NADP+:NADPH ratio were per-
formed by using the NADP+/NADPH-Glo(TM) Assay
(Promega) as per the manufacturer’s instructions; 250lM
diamide was used as a positive control.
Data analysis
Bioluminescence data were analyzed with PrismGraphpad
6. Baseline subtraction was performed to detrend traces (24-h
moving average or polynomial line fitting). Period, phase,
and amplitude were determined by least-square fitting to a
circadian damped cos wave with a linear baseline:
y¼ mxþ cð Þþ a exp kx cos 2px r
p
 
where m is the gradient of the baseline, c is the y offset, k
describes the damping rate, a is the amplitude, r is the phase,
and p is the period. The first 24 h of data were omitted from
analysis to exclude the transient effects in clock gene ex-
pression that frequently occur on a media change. When in-
dicated, the cos wave fit was compared with the straight-line
fit; p-value indicates rejection of the straight line.
Recent work has revealed that luciferin itself (non-
specifically) lengthens the circadian period by *1 h at high
concentrations (£2.5mM) (29). To distinguish biologically
relevant from statistically significant but non-specific effects
on the cellular clock, informed by the excellent paper from
the Ueda lab (36), we define a biologically relevant effect on
period as being >5% and >3 standard deviations different
than controls. In practice, this means that only changes in a
period of >1 h are considered noteworthy.
Western blotting
Western blots were performed according to standard pro-
tocols, using NuPAGE Novex 4–12% Bis-Tris Protein
Gels (ThermoFisher). Transfer to nitrocellulose membranes
was achieved by using the iBlot dry blotting system (Ther-
moFisher). Blots were incubated with blocking buffer con-
sisting of 0.125% bovine serum albumin (Sigma) and 0.125%
milk powder (Marvel). PER2::VENUS was detected by us-
ing anti-GFP antibody (Sigma), G6PDH (Abcam; ab993),
GPI (Abcam; 66340), NRF2 (Santa Cruz; sc-722), actin
(Santa Cruz; sc-47778), and PRX-SO2/3 (Abcam; ab16830).
Western blots were imaged on a Biorad chemidoc and
quantifications were performed in FIJI (69), measuring in-
tegrated density of the bands. Protein expression was ex-
pressed relative to tubulin expression or Coomaasie stain of
the gel, as indicated. Full annotated images for all blots are
presented in Supplementary Figures S12 to S15.
Acknowledgments
The authors thank Alessandra Stangherlin, Rachel Edgar,
and David Wong for valuable discussions. They would also
like to thank all their reviewers for their constructive com-
ments. M.P. was supported by the Dutch Cancer Foundation
(KWF, BUIT-2014-6637) and EMBO (ALTF-654-2014).
J.S.O. was supported by the Medical Research Council
(MC_UP_1201/4) and theWellcome Trust (093734/Z/10/Z).
Author Disclosure Statement
No competing financial interests exist.
References
1. Albrecht U, Albrecht U, Zheng B, Larkin D, Sun ZS, and
Lee CC. mPer1 and mPer2 are essential for normal resetting
of the circadian clock. J Biol Rhythms 16: 100–104, 2001.
2. Altman BJ, Hsieh AL Sengupta A, Krishnanaiah SY, Stine
ZE, Walton ZE, et al. MYC disrupts the circadian clock
CIRCADIAN PERIOD IS ROBUST AGAINST REDOX STRESS 11
D
ow
nl
oa
de
d 
by
 8
0.
6.
11
2.
99
 fr
om
 o
nl
in
e.l
ie
be
rtp
ub
.co
m
 at
 0
8/
14
/1
7.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
and metabolism in cancer cells. Cell Metab 22: 1009–1019,
2015.
3. Archer SN, Laing EE, Moller-Levet CS, van der Veen DR,
Bucca G, Lazar AS, et al.Mistimed sleep disrupts circadian
regulation of the human transcriptome. Proc Natl Acad Sci
U S A 111: E682–E691, 2014.
4. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C,
Kreppel F, et al. SIRT1 regulates circadian clock gene
expression through PER2 deacetylation. Cell 134: 317–328,
2008.
5. Asher G and Schibler U. Crosstalk between components of
circadian and metabolic cycles in mammals. Cell Metab 13:
125–137, 2011.
6. Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM,
and Weaver DR. Differential functions of mPer1, mPer2,
and mPer3 in the SCN circadian clock. Neuron 30: 525–
536, 2001.
7. Balsalobre A, Brown SA, Marcacci L, Tronche F, Kellen-
donk C, Reichardt HM, et al. Resetting of circadian time in
peripheral tissues by glucocorticoid signaling. Science 289:
2344–2347, 2000.
8. Balsalobre A, Damiola F, and Schibler U. A serum shock
induces circadian gene expression in mammalian tissue
culture cells. Cell 93: 929–937, 1998.
9. Balsalobre A, Marcacci L, and Schibler U. Multiple sig-
naling pathways elicit circadian gene expression in cultured
rat-1 fibroblasts. Curr Biol 10: 1291–1294, 2000.
10. Barban S and Schulze H. The effects of 2-deoxyglucose on
the growth and metabolism of cultured human cells. J Biol
Chem 236: 1887–1890, 1961.
11. Bass J. Circadian topology of metabolism. Nature 491:
348–356, 2012.
12. Belden WJ, Larrondo LF, Froehlich AC, Shi M, Chen CH,
Loros JJ, et al. The band mutation in Neurospora crassa is
a dominant allele of ras-1 implicating RAS signaling in
circadian output. Genes Dev 21: 1494–1505, 2007.
13. Brekke EMF, Walls AB, Schousboe A, Waagepetersen HS,
and Sonnewald U. Quantitative importance of the pentose
phosphate pathway determined by incorporation of 13C
from [2-13C]- and [3-13C]glucose into TCA cycle inter-
mediates and neurotransmitter amino acids in functionally
intact neurons. J Cereb Blood Flow Metab 32: 1788–1799,
2012.
14. Brown SA. Circadian clock-mediated control of stem cell
division and differentiation: beyond night and day. Devel-
opment 141: 3105–3111, 2014.
15. Burke TM, Markwald RR, Mchill AW, Chinoy ED, Snider
JA, Bessman SC, et al. Effects of caffeine on the human
circadian clock in vivo and in vitro. Sci Transl Med 7: 1–8,
2015.
16. Causton HC, Feeney KA, Ziegler CA, and O’Neill JS.
Metabolic cycles in yeast share features conserved among
circadian rhythms. Curr Biol 25: 1056–1062, 2015.
17. Cho C-S, Yoon HJ, Kim JY, Woo HA, and Rhee SG.
Circadian rhythm of hyperoxidized peroxiredoxin II is de-
termined by hemoglobin autoxidation and the 20S protea-
some in red blood cells. Proc Natl Acad Sci U S A 111:
12043–12048, 2014.
18. Chokkathukalam A, Kim D-H, Barrett MP, Breitling R, and
Creek DJ. Stable isotope-labeling studies in metabolomics:
new insights into structure and dynamics of metabolic
networks. Bioanalysis 6: 511–524, 2014.
19. Christensen CE, Karlsson M, Winther JR, Jensen PR, and
Lerche MH. Non-invasive in-cell determination of free
cytosolic [NAD+]/[NADH] ratios using hyperpolarized
glucose show large variations in metabolic phenotypes. J
Biol Chem 289: 2344–2352, 2014.
20. Cuesta M, Cermakian N, and Boivin DB. Glucocorticoids
entrain molecular clock components in human peripheral
cells. FASEB J 29: 1360–1370, 2014.
21. D’Alessandro M, Beesley S, Kim JK, Chen R, Abich E,
Cheng W, et al. A tunable artificial circadian clock in
clock-defective mice. Nat Commun 6: 8587, 2015.
22. Damiola F, Le Minli N, Preitner N, Kornmann B, Fleury-
Olela F, and Schibler U. Restricted feeding uncouples cir-
cadian oscillators in peripheral tissues from the central
pacemaker in the suprachiasmatic nucleus. Genes Dev 14:
2950–2961, 2000.
23. Dickinson BC and Chang CJ. Chemistry and biology of
reactive oxygen species in signaling or stress responses.
Nat Chem Biol 7: 504–511, 2011.
24. Dunlap JC. Molecular bases for circadian clocks. Cell 96:
271–290, 1999.
25. Dusick JR, Glenn TC, Lee WP, Vespa PM, Kelly DF, Lee
SM, et al. Increased pentose phosphate pathway flux after
clinical traumatic brain injury: a [1,2-13C2]glucose label-
ing study in humans. J Cereb Blood Flow Metab 27: 1593–
1602, 2007.
26. Eberhart K, Renner K, Ritter I, Kastenberger M, Singer K,
Hellerbrand C, et al. Low doses of 2-deoxy-glucose sen-
sitize acute lymphoblastic leukemia cells to glucocorticoid-
induced apoptosis. Leukemia 23: 2167–2170, 2009.
27. Edgar RS, Green EW, Zhao Y, van Ooijen G, Olmedo M,
Qin X, et al. Peroxiredoxins are conserved markers of
circadian rhythms. Nature 485: 459–464, 2012.
28. Feeney KA, Hansen LLL, Putker M, Olivares-Yan˜ez C,
Day J, Eades LJ, et al. Daily magnesium fluxes regulate
cellular timekeeping and energy balance. Nature 532: 375–
379, 2016.
29. Feeney KA, Putker M, Brancaccio M, and ONeill JS. In-
depth characterization of firefly luciferase as a reporter of
circadian gene expression in mammalian cells. J Biol
Rhythms 31: 540–550, 2016.
30. Feneberg R and Lemmer B. Circadian rhythm of glucose
uptake in cultures of skeletal muscle cells and adipocytes in
wistar-kyoto, wistar, goto-kakizaki, and spontaneously hy-
pertensive rats. Chronobiol Int 21: 521–538, 2004.
31. Gordon G, Mackow MC, and Levy HR. On the mecha-
nism of interaction of steroids with human glucose 6-
phosphate dehydrogenase. Arch Biochem Biophys 318:
25–29, 1995.
32. Gyo¨ngyo¨si N, Nagy D, Makara K, Ella K, and Ka´ldi K.
Reactive oxygen species can modulate circadian phase and
period in Neurospora crassa. Free Radic Biol Med 58: 134–
143, 2013.
33. Hastings MH, Reddy AB, and Maywood ES. A clockwork
web: circadian timing in brain and periphery, in health and
disease. Nat Rev Neurosci 4: 649–661, 2003.
34. Hirayama J, Cho S, and Sassone-Corsi P. Circadian control
by the reduction/oxidation pathway: catalase represses
light-dependent clock gene expression in the zebrafish.
Proc Natl Acad Sci U S A 104: 15747–15752, 2007.
35. Holmstro¨m KM and Finkel T. Cellular mechanisms and
physiological consequences of redox-dependent signalling.
Nat Rev Mol Cell Biol 15: 411–421, 2014.
36. Isojima Y, Nakajima M, Ukai H, Fujishima H, Yamada
RG, Masumoto K, et al. CKIepsilon/delta-dependent
phosphorylation is a temperature-insensitive, period-determining
12 PUTKER ET AL.
D
ow
nl
oa
de
d 
by
 8
0.
6.
11
2.
99
 fr
om
 o
nl
in
e.l
ie
be
rtp
ub
.co
m
 at
 0
8/
14
/1
7.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
process in the mammalian circadian clock. Proc Natl Acad
Sci U S A 106: 15744–15749, 2009.
37. Kil IS, Lee SK, Ryu KW, Woo HA, Hu MC Bae SH, et al.
Feedback control of adrenal steroidogenesis via H2O2-
dependent, reversible inactivation of peroxiredoxin III in
mitochondria. Mol Cell 46: 584–594, 2012.
38. Krishnaiah SY, Wu G, Altman BJ, Growe J, Rhoades SD,
Coldren F, et al. Clock regulation of metabolites reveals
coupling between transcription and metabolism. Cell Metab
25: 961–974.e4, 2017.
39. Kurtoglu M, Gao N, Shang J, Maher JC, Lehrman MA,
Wangpaichitr M, et al. Under normoxia, 2-deoxy-d-glucose
elicits cell death in select tumor types not by inhibition of
glycolysis but by interfering with N-linked glycosylation.
Mol Cancer Ther 6: 3049–3058, 2007.
40. Lamia KA, Sachdeva UM, DiTacchio L, Williams EC,
Alvarez JG, Egan DF, et al. AMPK regulates the circadian
clock by cryptochrome phosphorylation and degradation.
Science 326: 437–440, 2009.
41. Liberti MV and Locasale JW. The Warburg effect: how
does it benefit cancer cells? Trends Biochem Sci 41: 211–
218, 2016.
42. Liu AC, Tran HG, Zhang EE, Priest AA, Welsh DK, and
Kay SA. Redundant function of REV-ERBalpha and beta
and non-essential role for Bmal1 cycling in transcriptional
regulation of intracellular circadian rhythms. PLoS Genet 4:
e1000023, 2008.
43. Lowrey PL, Shimomura K, Antoch MP, Yamazaki S, Ze-
menides PD, Ralph MR, et al. Positional syntenic cloning
and functional characterization of the mammalian circadian
mutation tau. Science 288: 483–492, 2000.
44. Meng Q-JJ, Logunova L, Maywood ES, Gallego M, Le-
biecki J, Brown TM, et al. Setting clock speed in mammals:
the CK1 epsilon tau mutation in mice accelerates circadian
pacemakers by selectively destabilizing PERIOD proteins.
Neuron 58: 78–88, 2008.
45. Mohawk JA, Green CB, and Takahashi JS. Central and
Peripheral circadian clocks in mammals. Annu Rev Neu-
rosci 35: 445–462, 2012.
46. Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama
J, Chen D, et al. The NAD+-dependent deacetylase SIRT1
modulates CLOCK-mediated chromatin remodeling and
circadian control. Cell 134: 329–340, 2008.
47. Nangle SN, Rosensweig C, Koike N, Tei H, Takahashi JS,
and Carla B. Molecular assembly of the period-
cryptochrome circadian transcriptional repressor complex.
Elife 3: e03674, 2014.
48. O’Neill JS and Hastings MH. Increased coherence of cir-
cadian rhythms in mature fibroblast cultures. J Biol
Rhythms 23: 483–488, 2008.
49. O’Neill JS, Maywood ES, and Hastings MH. Cellular
mechanisms of circadian pacemaking: beyond transcrip-
tional loops. Handb Exp Pharmacol 67–103, 2013.
50. O’Neill JS, Ooijen GV, Dixon LE, Troein C, Corellou F,
Bouget F-Y, et al. Circadian rhythms persist without tran-
scription in a eukaryote. Nature 469: 554–558, 2011.
51. O’Neill JS and Reddy AB. Circadian clocks in human red
blood cells. Nature 469: 498–503, 2011.
52. Ortiz-Tudela E, Innominato PF, Rol MA, Le´vi F, and
Madrid JA. Relevance of internal time and circadian
robustness for cancer patients. BMC Cancer 16: 285,
2016.
53. Peek CB, Affinati AH, Ramsey KM, Kuo H-Y, Yu W, Sena
LA, et al. Circadian clock NAD+ cycle drives mitochon-
drial oxidative metabolism in mice. Science 342: 1243417,
2013.
54. Pekovic-Vaughan V, Gibbs J, Yoshitane H, Yang N, Pa-
thiranage D, Guo B, et al. The circadian clock regulates
rhythmic activation of the NRF2/glutathionemediated an-
tioxidant defense pathway to modulate pulmonary fibrosis.
Genes Dev 28: 548–560, 2014.
55. Pietzke M, Zasada C, Mudrich S, and Kempa S.
Decoding the dynamics of cellular metabolism and the
action of 3-bromopyruvate and 2-deoxyglucose using
pulsed stable isotope-resolved metabolomics. Cancer
Metab 2: 9, 2014.
56. Putker M and O’Neill JS. Reciprocal control of the circa-
dian clock and cellular redox state—a critical appraisal.
Mol Cells 39: 6–19, 2016.
57. Raghuram S, Stayrook KR, Huang P, Rogers PM, Nosie
AK, McClure DB, et al. Identification of heme as the
ligand for the orphan nuclear receptors REV-ERBalpha
and REV-ERBbeta. Nat Struct Mol Biol 14: 1207–1213,
2007.
58. Ramsey KM, Yoshino J, Brace SC, Abrassart D, Kobayashi
Y, Mercheva B, et al. Circadian clock feedback cycle
through NAMPT-mediated NAD+ biosynthesis. Science
324: 651–654, 2009.
59. Reppert SM and Weaver DR. Coordination of circadian
timing in mammals. Nature 418: 935–941, 2002.
60. Rey G and Reddy AB. Interplay between cellular redox
oscillations and circadian clocks. Diabetes Obes Metab 17:
55–64, 2015.
61. Rey G, Valekunja UK, Feeney KA, Wulund L, Milev
NB, Stangherlin A, et al. The pentose phosphate path-
way regulates the circadian clock. Cell Metab 24: 1–12,
2016.
62. Riganti C, Gazzano E, Polimeni M, Costamagna C, Bosia
A, and Ghigo D. Diphenyleneiodonium inhibits the cell
redox metabolism and induces oxidative stress. J Biol
Chem 279: 47726–47731, 2004.
63. Roenneberg T and Merrow M. Life before the clock:
modeling circadian evolution. J Biol Rhythms 17: 495–505,
2002.
64. Roenneberg T and Merrow M. The circadian clock and
human health. Curr Biol 26: R432–R443, 2016.
65. Saini C, Morf J, Stratmann M, Gos P, and Schibler U.
Simulated body temperature rhythms reveal the phase-
shifting behavior and plasticity of mammalian circadian
oscillators. Genes Dev 26: 567–580, 2012.
66. Sakai K, Hasumi K, and Endo A. Inactivation of rab-
bit muscle glyceraldehyde-3-phosphate dehydrogenase
by koningic acid. Biochim Biophys Acta 952: 297–303,
1988.
67. Sancar A, Lindsey-Boltz LA, Kang T-H, Reardon JT, Lee
JH, and Ozturk N. Circadian clock control of the cellular
response to DNA damage. FEBS Lett 584: 2618–2625,
2010.
68. Schibler U, Gotic I, Saini C, Gos P, Curie T, Emmenegger
Y, et al. Clock-talk: interactions between central and pe-
ripheral circadian oscillators in mammals. Cold Spring
Harb Symp Quant Biol 80: 223–232, 2016.
69. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V,
Longair M, Pietzsch T, et al. Fiji: an open-source platform
for biological-image analysis. Nat Methods 9: 676–682,
2012.
70. Schmalen I, Reischl S, Wallach T, Klemz R, Grudziecki A,
Prabu JR, et al. Interaction of circadian clock proteins
CIRCADIAN PERIOD IS ROBUST AGAINST REDOX STRESS 13
D
ow
nl
oa
de
d 
by
 8
0.
6.
11
2.
99
 fr
om
 o
nl
in
e.l
ie
be
rtp
ub
.co
m
 at
 0
8/
14
/1
7.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
CRY1 and PER2 Is modulated by zinc binding and dis-
ulfide bond formation. Cell 157: 1203–1215, 2014.
71. Seluanov A, Vaidya A, and Gorbunova V. Establishing
primary adult fibroblast cultures from rodents. J Vis Exp
pii: 2033, 2010.
72. Shigeyoshi Y, Taguchi K, Yamamoto S, Takekida S,
Yan L, Tei H, et al. Light-induced resetting of a mam-
malian circadian clock is associated with rapid in-
duction of the mPer1 transcript. Cell 91: 1043–1053,
1997.
73. Smyllie NJ, Pilorz V, Boyd J, Meng Q-J, Saer B, Chesham
JE, et al. Visualizing and quantifying intracellular behavior
and abundance of the core circadian clock protein PERI-
OD2. Curr Biol 26: 1–7, 2016.
74. Street JC, Mahmood U, Ballon D, Alfieri AA, and Koutcher
JA. 13C and 13P NMR investigation of effect of 6-
aminonicotinamide on metabolism of RIF-1 tumor cells
in vitro. J Biol Chem 271: 4113–4119, 1996.
75. Welsh DK, Yoo S-H, Liu AC, Takahashi JS, and Kay
SA. Bioluminescence imaging of individual fibro-
blasts reveals persistent, independently phased circadian
rhythms of clock gene expression. Curr Biol 14: 2289–
2295, 2004.
76. Wu L and Reddy AB. Rethinking the clockwork: redox
cycles and non-transcriptional control of circadian rhythms.
Biochem Soc Trans 42: 1–10, 2014.
77. Xu J. Preparation, culture, and immortalization of mouse
embryonic fibroblasts. Curr Protoc Mol Biol Chapter 28:
1–8, 2005.
78. Xue M, Momiji H, Rabbani N, Barker G, Bretschneider T,
Shmygol A, et al. Frequency modulated translocational
oscillations of Nrf2 mediate the antioxidant response ele-
ment cytoprotective transcriptional response. Antioxid Re-
dox Signal 23: 613–629, 2014.
79. Yoo S-H, Yamazaki S, Lowrey PL, Shimomura K, Ko CH,
Buhr ED, et al. PERIOD2::LUCIFERASE real-time re-
porting of circadian dynamics reveals persistent circadian
oscillations in mouse peripheral tissues. Proc Natl Acad Sci
U S A 101: 5339–5346, 2004.
80. Yoshida Y, Iigusa H, Wang N, and Hasunuma K. Cross-
talk between the cellular redox state and the circadian
system in Neurospora. PLoS One 6: e28227, 2011.
81. Yoshii K, Ishijima S, and Sagami I. Effects of NAD(P)H
and its derivatives on the DNA-binding activity of NPAS2,
a mammalian circadian transcription factor. Biochem Bio-
phys Res Commun 437: 386–391, 2013.
Address correspondence to:
Dr. John S. O’Neill
MRC Laboratory of Molecular Biology
Francis Crick Avenue
Cambridge CB2 0QH
United Kingdom
E-mail: oneillj@mrc-lmb.cam.ac.uk
Date of first submission to ARS Central, September 30, 2016;
date of final revised submission, May 11, 2017; date of ac-
ceptance, May 15, 2017.
Abbreviations Used
2DG¼ 2-deoxyglucose
2ME¼ 2-mercaptoethanol
3-Br-Pyr¼ 3-bromopyruvate
6AN¼ 6-aminonicotinamide
ANOVA¼ analysis of variance
Anti A¼ antimycin A
CHX¼ cycloheximide
CT¼ circadian time
DHEA¼ dehydroepiandrosterone
DMSO¼ dimethyl sulfoxide
DPI¼ diphenyleneiodonium
ECAR¼ extracellular acidification rate
ETC¼ electron transport chain
FCCP¼ carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone
G6PDH¼ glucose-6-phosphate dehydrogenase
Glc¼ glucose
GOX¼ glucose oxidase
GPI¼ phosphoglucose isomerase
KA¼ koningic acid
LC-MS¼ liquid chromatography coupled to
mass spectrometry
LUC¼ luciferase
OCR¼ oxygen consumption rate
PPP¼ pentose phosphate pathway
PRX¼ peroxiredoxin
ROS¼ reactive oxygen species
ROT¼ rotenone
SEM¼ standard error of the mean
SFN¼ sulforaphane
TCA¼ tricarboxylic acid cycle
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